borderline significantp = 0.065
The use of key medications included ACE inhibitors/ARB (9.4% overall), with a higher, borderline significant usage in non-survivors (30.0%) compared to survivors (9.4%, p = 0.065).
The use of key medications included ACE inhibitors/ARB (9.4% overall), with a higher, borderline significant usage in non-survivors (30.0%) compared to survivors (9.4%, p = 0.065).
Demographic and clinical characteristics The mean age of participants was 42.56 ± 16.92 years, with non-survivors having a higher mean age (50.46 ± 20.03 years) than survivors (42.34 ± 16.80 years); however, this difference did not reach statistical significance (p = 0.172) (Table 2 ).